[Drug therapy for mitochondrial diseases].
Kuroda
Yasuhiro
Y
Department of Pediatrics, School of Medicine, University of Tokushima.
Naito
Etsuo
E
Touda
Yoshihiro
Y
D002331:Carnitine / Q000627:therapeutic use; D003067:Coenzymes; D003574:Cytochrome c Group / Q000627:therapeutic use*; D045304:Cytochromes c; D003999:Dichloroacetic Acid / Q000627:therapeutic use*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005486:Flavin Mononucleotide / Q000627:therapeutic use*; D006801:Humans; D028361:Mitochondrial Diseases / Q000188:drug therapy*; D019802:Succinic Acid / Q000627:therapeutic use; D013831:Thiamine / Q000627:therapeutic use*; D013835:Thiamine Pyrophosphate / Q000627:therapeutic use*; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000627:therapeutic use
D003067:Coenzymes; D003574:Cytochrome c Group; D004338:Drug Combinations; C017112:cytochrome C, flavin mononucleotide, thiamine pyrophosphate drug combination; D014451:Ubiquinone; D005486:Flavin Mononucleotide; D045304:Cytochromes c; D003999:Dichloroacetic Acid; D019802:Succinic Acid; C024989:coenzyme Q10; D013835:Thiamine Pyrophosphate; D002331:Carnitine; D013831:Thiamine